| Primary |
| Product Used For Unknown Indication |
22.7% |
| Osteomyelitis |
9.1% |
| Cellulitis |
6.8% |
| Head And Neck Cancer |
6.8% |
| Infection |
6.8% |
| Staphylococcal Infection |
6.8% |
| Bacteraemia |
4.5% |
| Endocarditis |
4.5% |
| Postoperative Infection |
4.5% |
| Staphylococcal Bacteraemia |
4.5% |
| Antibiotic Therapy |
2.3% |
| Arthritis Bacterial |
2.3% |
| Cardiac Valve Vegetation |
2.3% |
| Erysipelas |
2.3% |
| Intervertebral Disc Disorder |
2.3% |
| Intraspinal Abscess |
2.3% |
| Localised Infection |
2.3% |
| Osteoarthritis |
2.3% |
| Sepsis |
2.3% |
| Squamous Cell Carcinoma |
2.3% |
|
| Rash |
20.0% |
| Aspartate Aminotransferase Increased |
8.6% |
| Liver Function Test Abnormal |
8.6% |
| Tubulointerstitial Nephritis |
8.6% |
| White Blood Cell Count Decreased |
8.6% |
| Neutropenia |
5.7% |
| Crystal Urine |
2.9% |
| Drug Resistance |
2.9% |
| Fatigue |
2.9% |
| Hepatic Enzyme Increased |
2.9% |
| Hepatitis |
2.9% |
| Hepatitis Cholestatic |
2.9% |
| Inappropriate Schedule Of Drug Administration |
2.9% |
| Liver Injury |
2.9% |
| Neoplasm Malignant |
2.9% |
| No Adverse Event |
2.9% |
| Overdose |
2.9% |
| Pleural Effusion |
2.9% |
| Pyrexia |
2.9% |
| Rash Erythematous |
2.9% |
|
| Secondary |
| Sepsis |
11.7% |
| Product Used For Unknown Indication |
10.2% |
| Endocarditis |
9.8% |
| Intervertebral Discitis |
8.8% |
| Drug Use For Unknown Indication |
7.8% |
| Staphylococcal Infection |
7.8% |
| Abscess |
5.4% |
| Bronchopneumonia |
3.9% |
| Eczema |
3.9% |
| Lung Transplant |
3.9% |
| Vasculitis |
3.9% |
| Abscess Limb |
3.4% |
| Parkinson's Disease |
3.4% |
| Anxiety |
2.4% |
| Constipation |
2.4% |
| Depression |
2.4% |
| Insomnia |
2.4% |
| Pancreatic Insufficiency |
2.4% |
| Groin Pain |
2.0% |
| Hypertension |
2.0% |
|
| Septic Shock |
16.1% |
| Thrombocytopenia |
8.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.1% |
| Pancytopenia |
7.1% |
| Hepatitis |
5.4% |
| Optic Neuritis |
5.4% |
| Renal Failure |
5.4% |
| Vasculitis |
5.4% |
| White Blood Cell Count Decreased |
5.4% |
| Cerebral Haematoma |
3.6% |
| Medication Error |
3.6% |
| Neutropenia |
3.6% |
| Osteomyelitis |
3.6% |
| Pseudobulbar Palsy |
3.6% |
| Shock Haemorrhagic |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Transaminases Increased |
3.6% |
| Adrenal Disorder |
1.8% |
| Aggression |
1.8% |
| Agranulocytosis |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
8.0% |
| Nuclear Magnetic Resonance Imaging |
6.6% |
| Device Related Infection |
6.4% |
| Chemotherapy |
6.3% |
| Pain |
4.7% |
| Endocarditis |
3.7% |
| Nuclear Magnetic Resonance Imaging Brain |
3.5% |
| Gastritis Erosive |
3.1% |
| Supraventricular Tachycardia |
3.1% |
| Anxiety |
3.0% |
| Asthma |
2.8% |
| Liver Transplant |
2.6% |
| Staphylococcal Infection |
2.6% |
| Ulcerative Keratitis |
2.6% |
| Prophylaxis |
2.5% |
| Thrombosis Prophylaxis |
2.4% |
| Angiogram |
2.2% |
| Hypertension |
2.2% |
| Pseudomonas Infection |
2.2% |
|
| Pyrexia |
9.5% |
| Vomiting |
9.5% |
| Weight Decreased |
8.1% |
| Staphylococcal Infection |
6.8% |
| Tremor |
6.8% |
| Human Herpesvirus 8 Infection |
5.4% |
| Rash |
5.4% |
| Toxic Skin Eruption |
5.4% |
| Blood Creatine Phosphokinase Increased |
4.1% |
| Drug Ineffective |
4.1% |
| Hypotension |
4.1% |
| Neutropenia |
4.1% |
| Osteitis |
4.1% |
| Pneumonia |
4.1% |
| Sepsis |
4.1% |
| Skin Plaque |
4.1% |
| Acidosis |
2.7% |
| Anhedonia |
2.7% |
| Arrhythmia |
2.7% |
| Cardiac Failure |
2.7% |
|
